CHURC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.973600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.642600E-01
Normal-vs-Stage2
6.930200E-01
Normal-vs-Stage3
3.094800E-01
Normal-vs-Stage4
5.257400E-01
Stage1-vs-Stage2
7.391000E-01
Stage1-vs-Stage3
2.232400E-01
Stage1-vs-Stage4
2.974000E-01
Stage2-vs-Stage3
3.446600E-01
Stage2-vs-Stage4
1.806560E-01
Stage3-vs-Stage4
9.469800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.157600E-01
Normal-vs-AfricanAmerican
9.720600E-01
Normal-vs-Asian
1.338040E-01
Caucasian-vs-AfricanAmerican
6.531600E-01
Caucasian-vs-Asian
9.578200E-02
AfricanAmerican-vs-Asian
9.861500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.598400E-01
Normal-vs-Female
7.608200E-01
Male-vs-Female
5.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.295600E-01
Normal-vs-Age(41-60Yrs)
8.914800E-01
Normal-vs-Age(61-80Yrs)
6.307600E-01
Normal-vs-Age(81-100Yrs)
4.440200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.399000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.915200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.983400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.333600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.806000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.152600E-01
Normal-vs-Daily Drinker
3.291800E-01
Normal-vs-Weekly Drinker
6.348200E-01
Normal-vs-Occasional Drinker
7.906600E-01
Normal-vs-Social Drinker
8.580000E-01
Non Drinker-vs-Daily Drinker
8.610400E-01
Non Drinker-vs-Weekly Drinker
5.093600E-01
Non Drinker-vs-Occasional Drinker
1.068770E-01
Non Drinker-vs-Social Drinker
8.984400E-02
Daily Drinker-vs-Weekly Drinker
6.094200E-01
Daily Drinker-vs-Occasional Drinker
1.482430E-01
Daily Drinker-vs-Social Drinker
1.132790E-01
Weekly Drinker-vs-Occasional Drinker
5.422800E-01
Weekly Drinker-vs-Social Drinker
3.054400E-01
Occasional Drinker-vs-Social Drinker
4.851800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.639600E-02
Normal-vs-Grade 2
3.533700E-02
Normal-vs-Grade 3
3.547700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.264400E-01
Grade 1-vs-Grade 3
6.855000E-01
Grade 1-vs-Grade 4
7.639600E-02
Grade 2-vs-Grade 3
6.627400E-01
Grade 2-vs-Grade 4
3.533700E-02
Grade 3-vs-Grade 4
3.547700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.998600E-01
Normal-vs-NonDiabetic
5.910000E-01
Diabetic-vs-NonDiabetic
9.720200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.214800E-01
Normal-vs-NoPancreatitis
6.909200E-01
Pancreatitis-vs-NoPancreatitis
1.882570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.629800E-01
Normal-vs-N1
7.311600E-01
N0-vs-N1
8.171800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.552600E-01
Normal-vs-TP53-NonMutant
9.932800E-01
TP53-Mutant-vs-TP53-NonMutant
8.321000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
